Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-19

Clinical Trial Update: Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial comparing losartan to hydrochlorothiazide in adults with pre-hypertension and pre-diabetes; the study status has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Losartan (losartan)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Pre-hypertension, Pre-diabetes | Phase 2 | Status: TERMINATED